CCL2 and Duchenne muscular dystrophy: Another study conducted on muscle samples of young DMD patients (age 2 years) demonstrated an increase in expression of CCL2 mRNA in this presymptomatic phase [29]; this strengthens the idea that this chemokine is being released at an early stage of the disease and could influence the chemotaxis of infiltrating macrophages in DMD.